Delivery Order SPE2DX22D0010-SPE2D826FAB38
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for MS Continu ER 15 mg tablets (100 count) valued at $1,212.77 under a firm fixed price contract. This non-set-aside competitive award represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. The contract will be performed at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $5,497.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of MS Continuous Release Tablets 30mg, with an ultimate completion date of July 31, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor that serves...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitively competed delivery order valued at $8,327.64 on August 7, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which serves as a child contract to a larger vehicle, is scheduled for ultimate completion on August 8, 2025. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $247,197.12 by the Defense Logistics Agency's Medical Supply Chain on September 29, 2025. This firm fixed-price delivery order, with completion scheduled for September 30, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $5,287.68 by the Defense Logistics Agency's Medical Supply Chain on July 26, 2025. This competitively awarded, firm fixed-price contract is classified as a child order and carries an ultimate completion date of July 28, 2025. The award represents a small-value transaction typical of the company's extensive federal medical procurement activities supporting military and veteran...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,045.04 by the Defense Logistics Agency's Medical Supply Chain on August 17, 2025. This non-competitive delivery order represents a firm fixed price contract with an ultimate completion date of August 18, 2025, and is classified as a child contract under a larger indefinite delivery vehicle. The award demonstrates AmerisourceBergen's continued role...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $42,337.11 on August 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This competitively awarded, non-set-aside delivery order represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a total value of $999,999,999.00 and extends through December 2026. The delivery order utilizes...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,236.78 by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. This competitively awarded, firm fixed-price delivery order is classified as a child contract and carries an ultimate completion date of September 9, 2025. The contract represents a continuation of the company's ongoing role as a critical federal medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $1,173.52 by the Defense Logistics Agency's Medical Supply Chain on August 12, 2025. This firm fixed-price delivery order, which represents a child award under a larger contract vehicle, carries an ultimate completion date of August 13, 2025. The contract was competitively awarded with no set-aside designation and utilizes...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $79,564.50 by the Defense Logistics Agency's Medical Supply Chain on September 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 16, 2025. The delivery order represents a continuation of the company's role as a critical federal medical procurement vendor, supplying...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAB38Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency's Medical Supply Chain for 60 mg Multisource Continuous Tablets (MS Contin Tabs). The contract, awarded on October 2, 2025, carries a ceiling value of $8,248.33 under a firm fixed-price arrangement with an ultimate completion date of October 3, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. No set-aside designation was applied to this award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as part of its extensive portfolio supplying brand-name and generic medications to Defense Logistics Agency and Defense Health Agency healthcare systems. The company's track record demonstrates consistent performance through competitively awarded contracts involving delivery orders with firm fixed pricing across multiple therapeutic domains. This particular transaction reflects the routine pharmaceutical supply operations that support military and veteran healthcare systems under the overarching DLA Troop Support Medical prime contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 10/2/25 |